Taysha Gene Therapies Announces Inducement Grant

Taysha Gene Therapies announced an inducement grant under Nasdaq Listing Rule 5635(c)(4). The company is a clinical-stage biotechnology firm focused on AAV-based gene therapies for severe monogenic CNS diseases.